KIDNEY DISEASE RESEARCH & ASSISTANCE FUND (EIN 825125447) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Legal Domicile

Principal Officer

VIVIAN MONTANO

Phone

7605405034

Tax Period

2023-10-01 to 2024-09-30

KIDNEY DISEASE RESEARCH & ASSISTANCE FUND, founded in 2018, is a small nonprofit in the Diseases & Disorders sector that reported $230K in total revenue in fiscal year 2023. Revenue grew 13% year-over-year, indicating healthy expansion.

Mission

The Organization awards grants for Kidney diseases research and assistance programs. It ships humanitarian aid, produce and fruits to impoverished communities to help fight kidney and other degenerative diseases.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $230,033

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $230,033

Expense Breakdown

Grants Paid $229,113

Salaries & Benefits $0

Fundraising Expenses $570

Program Expenses $232,113

Other Expenses $4,110

TOTAL EXPENSES $233,793

Year-over-Year Comparison

	2023	2022	Change
Revenue	$230,033	$204,287	+0.1%
Expenses	$233,793	$210,061	+0.1%
Net Income	$-3,760	$-5,774	-0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Vivian Montano	President	005.00	Officer Director	$0	$0	$0
Natasha L Evans	Secretary/Treasurer	001.00	Officer Director	$0	$0	$0
Javier Lugo	Vice President	001.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$230,033	$233,793	$6,414	$-3,760
2023	$204,287	$210,061	$10,174	$-5,774
2022	$159,509	$148,423	$15,948	$11,086
2021	$140,337	$136,376	$4,862	$3,961
2020	$135,968	$135,100	$901	$868
2019	$135,086	$135,053	$33	$33

KIDNEY DISEASE RESEARCH & ASSISTANCE FUND